Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.

被引：0
|
作者：
Gennatas, C
Mouratidou, D
Tsavaris, N
Andreadis, C
Michalaki, V
Psychogios, J
Poulakaki, N
Gennatas, S
机构：
[1] Univ Athens, Areteion Hosp, Athens, Greece
[2] Theagenion Krankenhauses, Thessaloniki, Greece
[3] Univ Athens, Laiko Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：63S / 63S
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of eribulin in combination with gemcitabine in patients with advanced triple negative breast cancer.
    Michalaki, Vasiliki
    Fragulidis, Georgios
    Kondis, Ioannis
    Karvouni, Eleni
    Dafnios, Nikolaos
    Kotsiou, Antonia
    Vassiliou, Ioannis
    Papadimitriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer
    Zhu, A.
    Yuan, P.
    Wang, J.
    Fan, Y.
    Luo, Y.
    Cai, R.
    Zhang, P.
    Li, Q.
    Ma, F.
    Xu, B.
    CANCER RESEARCH, 2019, 79 (04)
  • [43] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer.
    Sym, Sun Jin
    Hong, Junshik
    Jung, Minkyu
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Lee, Won-Suk
    Baek, Jeong-Heum
    Shin, Dong Bok
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Addition of Bevacizumab to Vinorelbine-Platinum combination is efficacious in Heavily Pretreated HER2-Negative Metastatic Breast Cancer
    Ho, I. -Wei
    Tseng, Yi-Ru
    Liu, Chun-Yu
    Tsai, Yi-Fang
    Huang, Chi-Cheng
    Tseng, Ling-Ming
    Chao, Ta-Chung
    Lai, Jiun-, I
    JOURNAL OF CANCER, 2025, 16 (05): : 1726 - 1735
  • [45] Combination of liposomal doxorubicine plus gemcitabine in heavily pretreated metastatic breast cancer patients: A single center experience.
    Pablo Fusco, Juan
    Martin Romano, Patricia
    Castanon Alvarez, Eduardo
    Ceniceros, Lucia
    Legaspi, Jairo
    Espinos, Jaime
    Gil-Bazo, Ignacio
    Fernandez-Hidalgo, Oscar
    Aramendia, Jose M.
    Santisteban, Marta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Phase II study of gemcitabine (G) and vinorelbine (V) in metastatic breast cancer.
    Donadio, M
    Ritorto, G
    Novarino, A
    Bonazzi, G
    Coccorullo, Z
    Buffoni, L
    Occelli, M
    Bertetto, O
    ANNALS OF ONCOLOGY, 2000, 11 : 31 - 31
  • [47] Topotecan as single agent or in combination with carboplatin in pretreated and heavily pretreated patients with advanced ovarian cancer
    Martoni, A
    Pelusi, G
    De Jaco, P
    Taroni, B
    Cacciari, N
    Angelelli, B
    Marino, A
    Zamagni, C
    7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, : 253 - 256
  • [48] Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer.
    Gokmen, E
    Sezgin, C
    Karabulut, B
    Vazquez, A
    Sanal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
  • [49] Vinorelbine and gemcitabine is an effective and well tolerated combination for the treatment of patients with advanced non-small cell lung cancer.
    Beinert, T
    Kahnt, C
    Schweiger, M
    Fleischhacker, M
    Werner, TG
    Binder, D
    Mergenthaler, HG
    Possinger, K
    ANNALS OF ONCOLOGY, 2000, 11 : 110 - 110
  • [50] Gemcitabine monotherapy in patients with heavily pretreated metastatic breast cancer. Evaluation of clinical activity and toxicity. NCI Slovakia Experience
    Salek, Tomas
    Mardiak, J.
    Dolinsky, J.
    Koza, I.
    ANNALS OF ONCOLOGY, 2004, 15 : 54 - 54
12345